drugset / Trial / NCT05015361

A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

NCT05015361 ↗

Phase 2 Completed 108 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of Remimazolam Tosilate for injection in local anesthesia assisted sedation, and to explore the dose range of remazolam toluenesulfonate for injection in local anesthesia assisted sedation.

Timeline

Start
2021-05-07
Primary completion
2021-06-18
Completion
2021-07-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule — —
Subject Remimazolam Small molecule — —

Indications

No indication recorded.